Developing biomarker-based tools for cancer screening, diagnosis, and treatment: the state of the science, evaluation, implementation, and economics : workshop summary
Gespeichert in:
| Beteilige Person: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | Englisch |
| Veröffentlicht: |
Washington, D.C.
National Academies Press
c2006
|
| Schlagwörter: | |
| Links: | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=178871 http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=178871 http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=178871 |
| Beschreibung: | Includes bibliographical references (p. 92) Cover -- Reviewers -- Contents -- Introduction -- Overview of Technologies Used to Discover Cancer Biomarkers -- Genomics, Proteomics, and Metabolomics -- Molecular Imaging -- Meeting the Technical Challenges of Biomarker Validation and Qualification -- Coordinating the Development of Biomarkers and Targeted Therapies -- Therapeutics Industry Perspective -- Diagnostics Industry Perspective -- NCI Perspective -- Clinical Investigator Perspective -- Biomarker Development and Regulatory Oversight -- FDA Critical Path Initiative -- Oversight of Diagnostic Tests -- Designing Clinical Studies of Biomarkers -- Assessment and Adoption of Biomarker-Based Technologies -- Federal Programs for Technology Assessment -- Insurance Coverage Decisions and Practice Guidelines -- CMS Coverage of Biomarkers -- Economic Impact of Biomarkers -- Cost-Effectiveness Analysis -- The Value of Information and Research -- Technology Assessment in the Private Sector -- Clinical Development Strategies for Biomarker Utilization Discussion -- Strategies for Implementing Standardized Biorepositories Discussion -- Strategies for Determining Analytic Validity and Clinical Utility of Biomarkers Discussion -- Strategies to Develop Biomarkers for Early Detection Discussion -- Mechanisms for Developing an Evidence Base Discussion -- Evaluation of Evidence in Decision Making Discussion -- Incorporating Biomarker Evidence Into Clinical Practice Discussion -- Acronyms -- Glossary -- References -- Appendixes -- Appendix A Workshop Agenda -- Appendix B Workshop Speakers, Moderators, Invited Discussants, and Participants -- Last Page |
| Umfang: | 1 Online-Ressource (x, 102 p.) |
| ISBN: | 0309101344 0309658144 1280704926 9780309101349 9780309658140 9781280704925 |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043096811 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151126s2006 xx o|||| 00||| eng d | ||
| 020 | |a 0309101344 |9 0-309-10134-4 | ||
| 020 | |a 0309658144 |c electronic bk. |9 0-309-65814-4 | ||
| 020 | |a 1280704926 |9 1-280-70492-6 | ||
| 020 | |a 9780309101349 |9 978-0-309-10134-9 | ||
| 020 | |a 9780309658140 |c electronic bk. |9 978-0-309-65814-0 | ||
| 020 | |a 9781280704925 |9 978-1-280-70492-5 | ||
| 035 | |a (OCoLC)80168779 | ||
| 035 | |a (DE-599)BVBBV043096811 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 616.99/4075 |2 22 | |
| 100 | 1 | |a Patlak, Margie |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Developing biomarker-based tools for cancer screening, diagnosis, and treatment |b the state of the science, evaluation, implementation, and economics : workshop summary |c Margie Patlak and Sharyl Nass, rapporteurs ; National Cancer Policy Forum |
| 264 | 1 | |a Washington, D.C. |b National Academies Press |c c2006 | |
| 300 | |a 1 Online-Ressource (x, 102 p.) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Includes bibliographical references (p. 92) | ||
| 500 | |a Cover -- Reviewers -- Contents -- Introduction -- Overview of Technologies Used to Discover Cancer Biomarkers -- Genomics, Proteomics, and Metabolomics -- Molecular Imaging -- Meeting the Technical Challenges of Biomarker Validation and Qualification -- Coordinating the Development of Biomarkers and Targeted Therapies -- Therapeutics Industry Perspective -- Diagnostics Industry Perspective -- NCI Perspective -- Clinical Investigator Perspective -- Biomarker Development and Regulatory Oversight -- FDA Critical Path Initiative -- Oversight of Diagnostic Tests -- Designing Clinical Studies of Biomarkers -- Assessment and Adoption of Biomarker-Based Technologies -- Federal Programs for Technology Assessment -- Insurance Coverage Decisions and Practice Guidelines -- CMS Coverage of Biomarkers -- Economic Impact of Biomarkers -- Cost-Effectiveness Analysis -- The Value of Information and Research -- Technology Assessment in the Private Sector -- Clinical Development Strategies for Biomarker Utilization Discussion -- Strategies for Implementing Standardized Biorepositories Discussion -- Strategies for Determining Analytic Validity and Clinical Utility of Biomarkers Discussion -- Strategies to Develop Biomarkers for Early Detection Discussion -- Mechanisms for Developing an Evidence Base Discussion -- Evaluation of Evidence in Decision Making Discussion -- Incorporating Biomarker Evidence Into Clinical Practice Discussion -- Acronyms -- Glossary -- References -- Appendixes -- Appendix A Workshop Agenda -- Appendix B Workshop Speakers, Moderators, Invited Discussants, and Participants -- Last Page | ||
| 650 | 7 | |a MEDICAL / Oncology |2 bisacsh | |
| 650 | 7 | |a HEALTH & FITNESS / Diseases / Cancer |2 bisacsh | |
| 650 | 7 | |a Tumor markers |2 fast | |
| 650 | 4 | |a Neoplasms / Congresses / prevention & control | |
| 650 | 4 | |a Mass Screening / Congresses / methods | |
| 650 | 4 | |a Tumor Markers, Biological / Congresses / analysis | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Tumor markers |v Congresses | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 700 | 1 | |a Nass, Sharyl J. |e Sonstige |4 oth | |
| 710 | 2 | |a National Cancer Policy Forum (U.S.) |e Sonstige |4 oth | |
| 710 | 2 | |a United States |b Department of Health and Human Services |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=178871 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA | ||
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-028521003 | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=178871 |l DE-1046 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=178871 |l DE-1047 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1818981231214198784 |
|---|---|
| any_adam_object | |
| author | Patlak, Margie |
| author_facet | Patlak, Margie |
| author_role | aut |
| author_sort | Patlak, Margie |
| author_variant | m p mp |
| building | Verbundindex |
| bvnumber | BV043096811 |
| collection | ZDB-4-EBA |
| ctrlnum | (OCoLC)80168779 (DE-599)BVBBV043096811 |
| dewey-full | 616.99/4075 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/4075 |
| dewey-search | 616.99/4075 |
| dewey-sort | 3616.99 44075 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04060nam a2200541zc 4500</leader><controlfield tag="001">BV043096811</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s2006 xx o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309101344</subfield><subfield code="9">0-309-10134-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309658144</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-309-65814-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1280704926</subfield><subfield code="9">1-280-70492-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309101349</subfield><subfield code="9">978-0-309-10134-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309658140</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-309-65814-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781280704925</subfield><subfield code="9">978-1-280-70492-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)80168779</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043096811</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/4075</subfield><subfield code="2">22</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Patlak, Margie</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Developing biomarker-based tools for cancer screening, diagnosis, and treatment</subfield><subfield code="b">the state of the science, evaluation, implementation, and economics : workshop summary</subfield><subfield code="c">Margie Patlak and Sharyl Nass, rapporteurs ; National Cancer Policy Forum</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C.</subfield><subfield code="b">National Academies Press</subfield><subfield code="c">c2006</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (x, 102 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (p. 92)</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Cover -- Reviewers -- Contents -- Introduction -- Overview of Technologies Used to Discover Cancer Biomarkers -- Genomics, Proteomics, and Metabolomics -- Molecular Imaging -- Meeting the Technical Challenges of Biomarker Validation and Qualification -- Coordinating the Development of Biomarkers and Targeted Therapies -- Therapeutics Industry Perspective -- Diagnostics Industry Perspective -- NCI Perspective -- Clinical Investigator Perspective -- Biomarker Development and Regulatory Oversight -- FDA Critical Path Initiative -- Oversight of Diagnostic Tests -- Designing Clinical Studies of Biomarkers -- Assessment and Adoption of Biomarker-Based Technologies -- Federal Programs for Technology Assessment -- Insurance Coverage Decisions and Practice Guidelines -- CMS Coverage of Biomarkers -- Economic Impact of Biomarkers -- Cost-Effectiveness Analysis -- The Value of Information and Research -- Technology Assessment in the Private Sector -- Clinical Development Strategies for Biomarker Utilization Discussion -- Strategies for Implementing Standardized Biorepositories Discussion -- Strategies for Determining Analytic Validity and Clinical Utility of Biomarkers Discussion -- Strategies to Develop Biomarkers for Early Detection Discussion -- Mechanisms for Developing an Evidence Base Discussion -- Evaluation of Evidence in Decision Making Discussion -- Incorporating Biomarker Evidence Into Clinical Practice Discussion -- Acronyms -- Glossary -- References -- Appendixes -- Appendix A Workshop Agenda -- Appendix B Workshop Speakers, Moderators, Invited Discussants, and Participants -- Last Page</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Oncology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / Cancer</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Tumor markers</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms / Congresses / prevention & control</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mass Screening / Congresses / methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tumor Markers, Biological / Congresses / analysis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tumor markers</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nass, Sharyl J.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">National Cancer Policy Forum (U.S.)</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">United States</subfield><subfield code="b">Department of Health and Human Services</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=178871</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028521003</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=178871</subfield><subfield code="l">DE-1046</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=178871</subfield><subfield code="l">DE-1047</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| id | DE-604.BV043096811 |
| illustrated | Not Illustrated |
| indexdate | 2024-12-20T17:28:02Z |
| institution | BVB |
| isbn | 0309101344 0309658144 1280704926 9780309101349 9780309658140 9781280704925 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028521003 |
| oclc_num | 80168779 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 Online-Ressource (x, 102 p.) |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 2006 |
| publishDateSearch | 2006 |
| publishDateSort | 2006 |
| publisher | National Academies Press |
| record_format | marc |
| spelling | Patlak, Margie Verfasser aut Developing biomarker-based tools for cancer screening, diagnosis, and treatment the state of the science, evaluation, implementation, and economics : workshop summary Margie Patlak and Sharyl Nass, rapporteurs ; National Cancer Policy Forum Washington, D.C. National Academies Press c2006 1 Online-Ressource (x, 102 p.) txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references (p. 92) Cover -- Reviewers -- Contents -- Introduction -- Overview of Technologies Used to Discover Cancer Biomarkers -- Genomics, Proteomics, and Metabolomics -- Molecular Imaging -- Meeting the Technical Challenges of Biomarker Validation and Qualification -- Coordinating the Development of Biomarkers and Targeted Therapies -- Therapeutics Industry Perspective -- Diagnostics Industry Perspective -- NCI Perspective -- Clinical Investigator Perspective -- Biomarker Development and Regulatory Oversight -- FDA Critical Path Initiative -- Oversight of Diagnostic Tests -- Designing Clinical Studies of Biomarkers -- Assessment and Adoption of Biomarker-Based Technologies -- Federal Programs for Technology Assessment -- Insurance Coverage Decisions and Practice Guidelines -- CMS Coverage of Biomarkers -- Economic Impact of Biomarkers -- Cost-Effectiveness Analysis -- The Value of Information and Research -- Technology Assessment in the Private Sector -- Clinical Development Strategies for Biomarker Utilization Discussion -- Strategies for Implementing Standardized Biorepositories Discussion -- Strategies for Determining Analytic Validity and Clinical Utility of Biomarkers Discussion -- Strategies to Develop Biomarkers for Early Detection Discussion -- Mechanisms for Developing an Evidence Base Discussion -- Evaluation of Evidence in Decision Making Discussion -- Incorporating Biomarker Evidence Into Clinical Practice Discussion -- Acronyms -- Glossary -- References -- Appendixes -- Appendix A Workshop Agenda -- Appendix B Workshop Speakers, Moderators, Invited Discussants, and Participants -- Last Page MEDICAL / Oncology bisacsh HEALTH & FITNESS / Diseases / Cancer bisacsh Tumor markers fast Neoplasms / Congresses / prevention & control Mass Screening / Congresses / methods Tumor Markers, Biological / Congresses / analysis Medizin Tumor markers Congresses (DE-588)1071861417 Konferenzschrift gnd-content Nass, Sharyl J. Sonstige oth National Cancer Policy Forum (U.S.) Sonstige oth United States Department of Health and Human Services Sonstige oth http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=178871 Aggregator Volltext |
| spellingShingle | Patlak, Margie Developing biomarker-based tools for cancer screening, diagnosis, and treatment the state of the science, evaluation, implementation, and economics : workshop summary MEDICAL / Oncology bisacsh HEALTH & FITNESS / Diseases / Cancer bisacsh Tumor markers fast Neoplasms / Congresses / prevention & control Mass Screening / Congresses / methods Tumor Markers, Biological / Congresses / analysis Medizin Tumor markers Congresses |
| subject_GND | (DE-588)1071861417 |
| title | Developing biomarker-based tools for cancer screening, diagnosis, and treatment the state of the science, evaluation, implementation, and economics : workshop summary |
| title_auth | Developing biomarker-based tools for cancer screening, diagnosis, and treatment the state of the science, evaluation, implementation, and economics : workshop summary |
| title_exact_search | Developing biomarker-based tools for cancer screening, diagnosis, and treatment the state of the science, evaluation, implementation, and economics : workshop summary |
| title_full | Developing biomarker-based tools for cancer screening, diagnosis, and treatment the state of the science, evaluation, implementation, and economics : workshop summary Margie Patlak and Sharyl Nass, rapporteurs ; National Cancer Policy Forum |
| title_fullStr | Developing biomarker-based tools for cancer screening, diagnosis, and treatment the state of the science, evaluation, implementation, and economics : workshop summary Margie Patlak and Sharyl Nass, rapporteurs ; National Cancer Policy Forum |
| title_full_unstemmed | Developing biomarker-based tools for cancer screening, diagnosis, and treatment the state of the science, evaluation, implementation, and economics : workshop summary Margie Patlak and Sharyl Nass, rapporteurs ; National Cancer Policy Forum |
| title_short | Developing biomarker-based tools for cancer screening, diagnosis, and treatment |
| title_sort | developing biomarker based tools for cancer screening diagnosis and treatment the state of the science evaluation implementation and economics workshop summary |
| title_sub | the state of the science, evaluation, implementation, and economics : workshop summary |
| topic | MEDICAL / Oncology bisacsh HEALTH & FITNESS / Diseases / Cancer bisacsh Tumor markers fast Neoplasms / Congresses / prevention & control Mass Screening / Congresses / methods Tumor Markers, Biological / Congresses / analysis Medizin Tumor markers Congresses |
| topic_facet | MEDICAL / Oncology HEALTH & FITNESS / Diseases / Cancer Tumor markers Neoplasms / Congresses / prevention & control Mass Screening / Congresses / methods Tumor Markers, Biological / Congresses / analysis Medizin Tumor markers Congresses Konferenzschrift |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=178871 |
| work_keys_str_mv | AT patlakmargie developingbiomarkerbasedtoolsforcancerscreeningdiagnosisandtreatmentthestateofthescienceevaluationimplementationandeconomicsworkshopsummary AT nasssharylj developingbiomarkerbasedtoolsforcancerscreeningdiagnosisandtreatmentthestateofthescienceevaluationimplementationandeconomicsworkshopsummary AT nationalcancerpolicyforumus developingbiomarkerbasedtoolsforcancerscreeningdiagnosisandtreatmentthestateofthescienceevaluationimplementationandeconomicsworkshopsummary AT unitedstatesdepartmentofhealthandhumanservices developingbiomarkerbasedtoolsforcancerscreeningdiagnosisandtreatmentthestateofthescienceevaluationimplementationandeconomicsworkshopsummary |